We are live on
!
Find out more
GP
Girard Partners Portfolio holdings
AUM
$1.06B
1-Year Est. Return
17.26%
This Fund
S&P 500
This Quarter
Est. Return
+7.68%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$564M
AUM Growth
+$34.3M
(+6.5%)
Cap. Flow
-$3.12M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
22.8%
Holding
982
New
716
Increased
64
Reduced
181
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.7M |
| 2 |
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
|
+$1.59M |
| 3 |
iShares MSCI EAFE Growth ETF
EFG
|
+$895K |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$638K |
| 5 |
Lockheed Martin
LMT
|
+$550K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.54M |
| 2 |
Johnson & Johnson
JNJ
|
+$2.21M |
| 3 |
Altria Group
MO
|
+$1.76M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$991K |
| 5 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
+$940K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.25% |
| 2 | Healthcare | 12.42% |
| 3 | Financials | 12.23% |
| 4 | Industrials | 9.48% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Bristol-Myers Squibb
BMY
$123B
| $1.35M | 0.24% |
21,823
-5,595
| -20% | -$332K |
|
102
Automatic Data Processing
ADP
$102B
| $1.31M | 0.23% |
8,689
-1,040
| -11% | -$147K |
|
103
iShares Core S&P 500 ETF
IVV
$879B
| $1.29M | 0.23% |
4,407
-390
| -8% | -$112K |
|
104
AbbVie
ABBV
$448B
| $1.29M | 0.23% |
13,631
-627
| -4% | -$59.5K |
|
105
Skyworks Solutions
SWKS
$8.99B
| $1.22M | 0.22% |
13,452
+301
| +2% | +$28.2K |
|
106
Intercontinental Exchange
ICE
$80.1B
| $1.21M | 0.21% |
16,158
+3,718
| +30% | +$280K |
|
107
Hasbro
HAS
$11.5B
| $1.19M | 0.21% |
11,275
-928
| -8% | -$92.9K |
|
|
ATVI
108
DELISTED
Activision Blizzard
ATVI
| $1.17M | 0.21% |
14,052
-114
| -0.8% | -$8.65K |
|
109
iShares Core US Aggregate Bond ETF
AGG
$138B
| $1.12M | 0.2% |
10,577
-2,951
| -22% | -$313K |
|
110
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $1.1M | 0.2% |
26,848
-2,633
| -9% | -$111K |
|
111
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.03B
| $1.1M | 0.19% |
16,238
-1,257
| -7% | -$84.5K |
|
112
VanEck High Yield Muni ETF
HYD
$4.5B
| $1.09M | 0.19% |
17,576
-506
| -3% | -$31.7K |
|
113
Gilead Sciences
GILD
$165B
| $1.09M | 0.19% |
14,159
-810
| -5% | -$61.2K |
|
114
Caterpillar
CAT
$398B
| $1.09M | 0.19% |
7,147
-984
| -12% | -$139K |
|
115
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
| $1.08M | 0.19% |
12,008
+34
| +0.3% | +$3.08K |
|
116
Bank of America
BAC
$424B
| $1.08M | 0.19% |
36,759
-6,460
| -15% | -$197K |
|
117
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
| $1.07M | 0.19% |
15,660
+126
| +0.8% | +$8.71K |
|
118
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
| $1.05M | 0.19% |
17,553
+3,012
| +21% | +$180K |
|
119
Clorox
CLX
$11.6B
| $1.03M | 0.18% |
6,853
-737
| -10% | -$105K |
|
120
TransDigm Group
TDG
$67.4B
| $979K | 0.17% |
2,631
-194
| -7% | -$69.9K |
|
121
Cummins
CMI
$88.2B
| $971K | 0.17% |
6,650
+199
| +3% | +$28K |
|
122
Monster Beverage
MNST
$93.4B
| $964K | 0.17% |
33,106
-444
| -1% | -$13.4K |
|
123
Vanguard FTSE Developed Markets ETF
VEA
$224B
| $937K | 0.17% |
21,662
-3,744
| -15% | -$161K |
|
124
Realty Income
O
$60.8B
| $890K | 0.16% |
16,145
-2,194
| -12% | -$121K |
|
125
Vanguard Small-Cap ETF
VB
$79.2B
| $882K | 0.16% |
5,429
-648
| -11% | -$105K |
|
Similar funds
PO
PRIG
KI
H
RVPG
AC
AT
IFAM
Girard Partners's Q3 2018 Portfolio in Review
As of Q3 2018, Girard Partners held 982 positions worth $564M, up 6.5% from $530M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Girard Partners's Q3 2018 filing shows 716 new, 64 increased, 181 reduced and 3 closed positions. Its largest new stake was Invesco Zacks Mid-Cap ETF: 5,985 shares worth $408K. The largest sale was Apple, an estimated $2.54M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- Girard Partners's largest Q3 2018 buy was Invesco Zacks Mid-Cap ETF: 5,985 shares worth $408K.
- Girard Partners added most to State Street SPDR Portfolio S&P 500 ETF in Q3 2018, an estimated $1.7M increase.
- Girard Partners's biggest Q3 2018 reduction was Apple, cutting an estimated $2.54M.
- Girard Partners fully exited Athenex, Inc. Common Stock in Q3 2018, selling an estimated $940K.
- Girard Partners's ten largest holdings make up 23% of its $564M portfolio in Q3 2018.
- Girard Partners opened 716 new positions and closed 3 in Q3 2018.
- Girard Partners's portfolio value rose 6.5% quarter-over-quarter to $564M.
Based on Girard Partners's 13F filing for Q3 2018, filed 9 Nov 2018.